Reshaping the landscape of locoregional treatments for breast cancer liver metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice in... by Bryan S. Margulies, Morakot Likhitpanichkul, Debu Tripathy

Get full text

AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization by Lan T. H. Phi, Yating Cheng, Yohei Funakoshi, Francois Bertucci, Pascal Finetti, Steven J. Van Laere, Fang Zou, James P. Long, Suguru Ogata, Savitri Krishnamurthy, James M. Reuben, Jason M. Foulks, Steven L. Warner, Jennifer M. Rosenbluth, Anil K. Sood, Debu Tripathy, Naoto T. Ueno, Xiaoping Wang

Get full text

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer by Nicole M. Kettner, Tuyen N. Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo, Nghi Lam, Xiayu Rao, Akshara Singareeka Raghavendra, Yan Wang, Nancy Azizian, T. Kris Eckols, Moses Makokha Kasembeli, Kurt Evans, Min Yi, Hannah Wingate, Jing Wang, Aysegul A. Sahin, Funda Meric-Bernstam, Kelly K. Hunt, Senthil Damodaran, David J. Tweardy, Debu Tripathy, Khandan Keyomarsi

Get full text